LANCEO: what changed
What changed
LANCEO
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
filed annual accounts (NBB)
Net result for the year
€39,841
2024 · €32,317+€7,524
Equity
€252,857
2024 · €213,016+€39,841
Cash
€52,429
2024 · €54,660-€2,231
Balance sheet total
€291,955
2024 · €249,869+€42,086
Largest movements
Assets
- Receivables within one year +€41,435
up €41,435 (+197%), from €21,055 to €62,490
of which Trade receivables: +€44,213
- Deferred charges and accrued income +€10,124
up €10,124 (+1,331%), from €760 to €10,884
- Tangible fixed assets -€8,798
down €8,798 (-75.3%), from €11,684 to €2,886
of which Furniture and vehicles: -€7,498
Equity and liabilities
- Reserves +€39,841
up €39,841 (+19.3%), from €206,816 to €246,657
- Tax, wage and social debts +€4,049
up €4,049 (+14.6%), from €27,744 to €31,793
Income statement
- Gross operating margin +€7,473
up €7,473 (+13.4%), from €55,644 to €63,117
- Taxes +€2,725
up €2,725 (+20.4%), from €13,387 to €16,112
- Financial income +€1,305
up €1,305 (+142%), from €918 to €2,224
- Depreciation -€791
down €791 (-8.3%), from €9,589 to €8,798
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€32,317
Gross operating margin
+€7,473
Depreciation
+€791
Other operating charges
+€378
Financial income
+€1,305
Financial charges
+€302
Taxes
-€2,725
Result 2025
€39,841
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€675
Investment
-€1,557
Financing
€0
Cash 2024
€54,660
From operations (derived)
-€675
Net result for the year
+€39,841
Depreciation
+€8,798
Receivables within one year
-€41,435
Deferred charges and accrued income
-€10,124
Trade debts
-€629
Tax, wage and social debts
+€4,049
Other debts
-€1,176
Investment (derived)
-€1,557
Current investments
-€1,557
Cash 2025
€52,429
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €249,869 | €291,955 | +€42,086 | +16.8% |
| Fixed assets | 21/28 | €11,684 | €2,886 | -€8,798 | -75.3% |
| Tangible fixed assets | 22/27 | €11,684 | €2,886 | -€8,798 | -75.3% |
| Plant, machinery and equipment | 23 | €1,434 | €544 | -€890 | -62.1% |
| Furniture and vehicles | 24 | €9,840 | €2,342 | -€7,498 | -76.2% |
| Other tangible fixed assets | 26 | €410 | - | -€410 | |
| Current assets | 29/58 | €238,185 | €289,069 | +€50,884 | +21.4% |
| Amounts receivable within one year | 40/41 | €21,055 | €62,490 | +€41,435 | +197% |
| Trade receivables | 40 | €18,106 | €62,319 | +€44,213 | +244% |
| Other amounts receivable | 41 | €2,949 | €171 | -€2,778 | -94.2% |
| Current investments | 50/53 | €161,709 | €163,266 | +€1,557 | +1.0% |
| Cash at bank and in hand | 54/58 | €54,660 | €52,429 | -€2,231 | -4.1% |
| Deferred charges and accrued income | 490/1 | €760 | €10,884 | +€10,124 | +1,331% |
| Total equity and liabilities | 10/49 | €249,869 | €291,955 | +€42,086 | +16.8% |
| Equity | 10/15 | €213,016 | €252,857 | +€39,841 | +18.7% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €206,816 | €246,657 | +€39,841 | +19.3% |
| Distributable reserves | 133 | €206,816 | €246,657 | +€39,841 | +19.3% |
| Amounts payable | 17/49 | €36,853 | €39,098 | +€2,245 | +6.1% |
| Amounts payable within one year | 42/48 | €36,853 | €39,098 | +€2,245 | +6.1% |
| Trade debts | 44 | €5,008 | €4,379 | -€629 | -12.6% |
| Suppliers | 440/4 | €5,008 | €4,379 | -€629 | -12.6% |
| Taxes, remuneration and social security | 45 | €27,744 | €31,793 | +€4,049 | +14.6% |
| Taxes | 450/3 | €27,744 | €31,793 | +€4,049 | +14.6% |
| Other amounts payable | 47/48 | €4,101 | €2,925 | -€1,176 | -28.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,589 | €8,798 | -€791 | -8.3% |
| Other operating charges | 640/8 | €741 | €364 | -€378 | -50.9% |
| Gross operating margin | 9900 | €55,644 | €63,117 | +€7,473 | +13.4% |
| Operating profit (loss) | 9901 | €45,313 | €53,955 | +€8,642 | +19.1% |
| Financial income | 75/76B | €918 | €2,224 | +€1,305 | +142% |
| Recurring financial income | 75 | €918 | €2,224 | +€1,305 | +142% |
| Financial charges | 65/66B | €527 | €225 | -€302 | -57.3% |
| Recurring financial charges | 65 | €424 | €225 | -€199 | -46.9% |
| Non-recurring financial charges | 66B | €103 | - | -€103 | |
| Profit (loss) for the period before taxes | 9903 | €45,704 | €55,954 | +€10,249 | +22.4% |
| Income taxes | 67/77 | €13,387 | €16,112 | +€2,725 | +20.4% |
| Profit (loss) for the period | 9904 | €32,317 | €39,841 | +€7,524 | +23.3% |
| Profit (loss) for the period to be appropriated | 9905 | €32,317 | €39,841 | +€7,524 | +23.3% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.